10
Jun
2010
Complix, NV: Series A $6.2M
Posted in I - Series A, Q - 2Q10, R - INTERNATIONAL, X - Alphabody, X - Antiinfective, X - Autoimmune
Complix (Belgium) a preclinical-stage biopharmaceutical focused on alphabody therapeutics for autoimmune and infectious diseases, closed a $6.2M Series A financing. Participants include Vesalius Biocapital, LRM and CRP Santé.
OnBioVC PARTNERS
-
